Article Versions Notes

Culp-Hill R, Stevens BM, Jones CL, Pei S, Dzieciatkowska M, Minhajuddin M, Jordan CT, D’Alessandro A. Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2. Metabolites. 2023; 13(4):467. https://doi.org/10.3390/metabo13040467

Culp-Hill, Rachel, Brett M. Stevens, Courtney L. Jones, Shanshan Pei, Monika Dzieciatkowska, Mohammad Minhajuddin, Craig T. Jordan, and Angelo D’Alessandro. 2023. "Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2" Metabolites 13, no. 4: 467. https://doi.org/10.3390/metabo13040467

Culp-Hill, R., Stevens, B. M., Jones, C. L., Pei, S., Dzieciatkowska, M., Minhajuddin, M., Jordan, C. T., & D’Alessandro, A. (2023). Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2. Metabolites, 13(4), 467. https://doi.org/10.3390/metabo13040467